| |
| |
|
| Insider
Information: |
Greenbelt Corp /ny |
| Relationship: |
See Remarks |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
1,143,346 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,051,764 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
1,143,346 |
|
|
| Total
Value |
$1,051,764 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Lineage Cell Therapeutics Ord Shs |
LCTX |
See Remarks |
2017-01-03 |
1,143,346 |
2003-10-08 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LCTX |
Lineage Cell Therapeutics... |
See Remarks |
– – – |
2017-01-03 |
4 |
D |
$0.00 |
$0 |
D/D |
(238,459) |
1,143,346 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
10% Owner |
– – • |
2014-01-15 |
5 |
GD |
$0.00 |
$0 |
D/D |
120,500 |
1,506,905 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
10% Owner |
– – • |
2013-01-01 |
5 |
GD |
$0.00 |
$0 |
D/D |
55,100 |
1,627,405 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
10% Owner |
– – • |
2012-10-25 |
5 |
D |
$0.00 |
$0 |
D/D |
(270,000) |
1,682,505 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
10% Owner |
– – • |
2012-09-01 |
5 |
GD |
$0.00 |
$0 |
D/D |
16,000 |
1,952,505 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
10% Owner |
– – • |
2012-06-01 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,000 |
1,968,505 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
10% Owner |
– – • |
2011-01-12 |
5 |
GD |
$0.00 |
$0 |
D/D |
2,400 |
1,970,505 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
10% Owner |
– – • |
2010-12-01 |
5 |
GD |
$0.00 |
$0 |
D/D |
19,800 |
1,972,905 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
10% Owner |
– – • |
2010-12-01 |
5 |
D |
$0.00 |
$0 |
D/D |
(150,000) |
1,992,705 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
10% Owner |
– – • |
2010-11-01 |
4 |
OE |
$2.00 |
$231,040 |
D/D |
115,520 |
2,142,705 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
10% Owner |
– – • |
2009-09-17 |
5 |
GD |
$0.00 |
$0 |
D/D |
31,800 |
2,066,185 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
10% Owner |
– – • |
2009-08-20 |
4 |
A |
$0.00 |
$0 |
D/D |
57,143 |
2,097,985 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
10% Owner |
– – • |
2009-07-31 |
4 |
GD |
$0.00 |
$0 |
D/D |
42,000 |
2,097,985 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
10% Owner |
– – • |
2009-04-15 |
4 |
A |
$0.00 |
$0 |
D/D |
3,429 |
2,082,842 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
10% Owner |
– – • |
2008-11-03 |
4 |
A |
$0.00 |
$0 |
D/D |
60,000 |
2,076,698 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
10% Owner |
– – • |
2008-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
300,000 |
2,016,698 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
13D Group-10% Owner |
– – – |
2007-04-16 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
1,716,698 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
13D Group-10% Owner |
– – – |
2007-04-02 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
1,686,698 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
13D Group-10% Owner |
– – – |
2007-01-16 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
1,636,698 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
13D Group-10% Owner |
– – – |
2006-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
135,000 |
1,456,698 |
|
- |
|
| LCTX |
Lineage Cell Therapeutics... |
officerTitle |
– – – |
2005-12-21 |
4 |
OE |
$0.40 |
$104,811 |
D/D |
262,028 |
1,321,698 |
|
- |
|
| LCTX |
Lineage Cell Therapeutics... |
13D Group-10% Owner |
– – – |
2004-11-02 |
4 |
A |
$0.00 |
$0 |
D/D |
60,000 |
1,059,670 |
|
- |
|
| LCTX |
Lineage Cell Therapeutics... |
13D Group-10% Owner |
– – – |
2004-01-21 |
4/A |
OE |
$1.40 |
$203,294 |
D/D |
145,210 |
999,670 |
|
- |
|
| LCTX |
Lineage Cell Therapeutics... |
13D Group-10% Owner |
– – – |
2004-01-21 |
4 |
OE |
$1.40 |
$135,530 |
D/D |
96,807 |
951,267 |
|
- |
|
| LCTX |
Lineage Cell Therapeutics... |
13D Group-10% Owner |
– – – |
2003-10-08 |
4 |
A |
$0.00 |
$0 |
D/D |
80,000 |
814,460 |
|
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
